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Conclusions: The methods developed in this study are based
on general principles, and showed a significant correlation with
a widely used grading protocol for a urine model of OA. The
usefulness of these methods for other animal models, other
grading protocols, and in treatment studies needs to be further
demonstrated.
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INTERLEUKIN-1 ALPHA IN COMPARISON TO
INTERLEUKIN-1 BETA IS A MORE POTENT STIMULATOR
OF AGGRECANASE MEDIATED AGGRECAN
DEGRADATION IN HUMAN ARTICULAR CARTILAGE
E.U. Sumer, B.-C. Sondergaard, S.H. Madsen, P. Qvist,
M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Aggrecan is the predominant proteoglycan in the ex-
tracellular matrix of articular cartilage. One of the early steps in
initiation of cartilage degradation is loss of proteoglycans, which
leads to further degradation of the collagen network. Interleukin-
1 (IL-1) is a potent pro-inflammatory cytokine associated with
the pathology of osteoarthritis (OA). However, controversy exists
regarding the potency of IL-1alpha (IL-1α) compared to IL-1beta
(IL-1β) on degradation of articular cartilage. Therefore, the aim
of the present work was to assess the potential of IL-1α and
IL-1β on human articular cartilage degradation, through quanti-
fying MMP and aggrecanase activity with special emphasis on
protease generated fragments of aggrecan.
Methods: Articular cartilage was obtained from OA patients un-
dergoing total kne arthroplasty. Articular cartilage explants were
cultured for 21 days with refreshment of medium every 3rd day
in the presence of 100 ng/mL IL-1α or 100 ng/mL IL-1β to stim-
ulate cartilage degradation. As negative control, explants were
cultured without stimulation. Cartilage degradation was moni-
tored by measuring the conditioned medium in 2 independent
sandwich assays (1) 342-G2 assay, composed of the capturing
antibody AF-28 against the 342FFGVG neo-epitope generated by
MMP-cleavage and the monoclonal antibody F-78 binding to both
the Globular 1 (G1) and Globular 2 (G2) domain of aggrecan; (2)
374-G2 assay, made up by the capturing antibody BC-3 against
the 374ARGSVI neo-epitope created by aggrecanase cleavage
and F-78.
Results: Both IL-1α or IL-1β stimulated aggrecanase mediated
cartilage degradation as measured by the 374-G2 assay. How-
ever, IL-1α was approximately 200% more potent in inducing
aggrecanase activity in human chondrocytes compared to IL-1β
at equimolar concentrations. Neither IL-1α or IL-1β treatment
of the human articular cartilage explants resulted in increased
release of MMP generated fragments of aggrecan quantified by
the 342-G2 assay.
Conclusions: Both IL-1α or IL-1β induce aggrecanases in hu-
man osteoarthritic cartilage. However, IL-1α seems to be approx-
imately 200% more potent than IL-1β, suggesting important dif-
ferences in cartilage metabolism induced by these two cytokines.
P86
ESTROGEN DEFICIENCY RESULTS IN INCREASED TYPE
II COLLAGEN DEGRADATION AND DECREASED
SYNTHESIS, WHICH LEAD TO INCREASED CARTILAGE
EROSION
A.K. Olsen1, B.-C. Sondergaard1, R.H. Nielsen1,
S. Oestergaard1, P. Qvist1, C. Christiansen2, M.A. Karsdal1
1Nordic Bioscience, Herlev, Denmark, 2CCBR, Ballerup, Denmark
Purpose: Cartilage degradation is a hallmark in osteoarthritis
(OA) and loss of estrogen has been shown to be associated
with increased prevalence of OA in postmenopausal women.
We investigated the effect of estrogen on cartilage health in the
ovariectomized (OVX) rat model by measuring collagen type II
degradation and a novel markers of collagen type II formation.
Methods: In vivo, forty 7-month old Sprague-Dawley rats were
divided into four groups. One group was subjected to sham op-
eration, whereas the others to OVX, followed by treatment with
either vehicle alone, 17-β-estradiol [0.25mg/pellet s.c. implanted]
initiated instantly after surgery and continued until termination
after 9 weeks. Serum was collected at baseline and week 4,
6 and 9 (termination), followed by quantification of telopep-
tides from collagen type II degradation(CTX-II) and fragments
of pro-peptides of type II collagen (PIINP) by ELISA. Cartilage
erosion was evaluated by histology through toluidine blue stain-
ing followed by microscopic measurement of the eroded articular
cartilage surfaces of the four condyles.
Results: Cartilage degradation (CTX-II) was significantly ele-
vated after week 2, P<0.001; 200%, and remained higher than
sham operated-rats throughout the nine weeks. In contrast, PI-
INP levels in OVX rats were significantly lower, P<0.05; 50%,
than sham-operated animals at week 6 and 9.
Treatment with estrogen to OVX rats resulted in a suppression of
CTX-II release to below sham-operated animals, P<0.01. With
regards to cartilage formation, estrogen treatment of OVX rats,
restored PIINP levels to sham levels, P<0.01. Histological eval-
uation of cartilage erosions in estrogen deficient (OVX) animals
compared to that of sham operated animals, displayed an 150%
increase in cartilage erosion, P<0.01. This was completely re-
stored to sham levels by estrogen replacement, P<0.01.
Conclusions: Loss of estrogen may result both in an increase
in cartilage degradation and a decrease in cartilage formation.
Consequently loss of estrogen results in increased cartilage ero-
sion. This emphasises the importance of measuring both tissue
formation and degradation when evaluating potential treatment
for OA.
P87
A LONGITUDINAL ANALYSIS OF SERUM CYTOKINES IN
THE HARTLEY GUINEA PIG MODEL OF
OSTEOARTHRITIS
J.L. Huebner, D.R. Seifer, V.B. Kraus
Duke University Medical Center, Durham, NC
Purpose: To examine the levels of a panel of cytokines in the
serum of Hartley guinea pigs ranging from 3 weeks to 18 months
of age in order to identify biochemical markers of osteoarthritis.
Methods: Forty six male Hartley guinea pigs were obtained from
Charles River Laboratories and sacrificed at time points from
3 weeks to 18 months of age, at which time blood samples
were obtained. Histological severity of knee OA was determined
using a semi-quantitative grading scheme described previously,
which assessed cartilage structure abnormalities and proteogly-
can loss. Cytokines and chemokines in the serum were mea-
sured using the Bio-Plex Protein Array System with the Bio-Plex
Mouse cytokine 18-Plex Panel. Cytokine concentrations were log
transformed to meet assumptions of normalcy. To differentiate
OA-related from purely age-related effects, we evaluated the
association between cytokine serum concentrations (pg/ml) and
total histological score for the cytokines that previously showed
a significant difference between age-matched animals differing
in OA susceptibility, namely the OA-prone Hartley strain and
the OA-resistant Strain 13. Standard correlation analyses and
multiple linear regression were performed using JMP Discovery
software. Values were considered significant after adjustment for
multiple testing using the Holm method.
Results: Histological OA presented at 4 months and significantly
